Neurology · 2002 · 65 citations · 5 references
MedicineOncologyPharmacologyChemotherapyHematologic OncologyMedical OncologyChemotherapy In Hematologic MalignanciesHematologic MalignanciesHematologic ToxicityToxicity ManagementAcute LeukemiasAcute Lymphoblastic Leukemia TherapyAcute Myeloid Leukemia ProgressionAcute Myeloid Leukemia TherapyAcute Myeloid Leukemia TreatmentAcute Promyelocytic LeukemiaMitoxantrone TherapySecondary Progressive Multiple Sclerosis Treatment
The authors report a patient with severe secondary progressive MS who responded to mitoxantrone but developed a fatal acute myeloblastic leukemia 15 months after completion of mitoxantrone therapy. Therapy-related acute leukemia (TRAL) in relation with mitoxantrone is rare; this patient was the first case among a cohort of 802 French MS patients treated with mitoxantrone. Nevertheless, this case stresses the need to further evaluate the long-term risk of TRAL in patients with MS who receive mitoxantrone.
5
Gilles Edan, David Miller, M. Clanet et al. · Journal of Neurology Neurosurgery & Psychiatry · 1997 · 422 citations · Full text
Pharmacy, Neurology, Pharmacotherapy +12
Multiple Sclerosis Journal · 1998 · 13 citations